| ARID1A | AT-Rich Interaction Domain 1A |
| ATM | ATM Serine/Threonine Kinase |
| AKT | AKT Serine/Threonine Kinase |
| ATR | ATR serine/threonine kinase |
| AUC | Area Under the Curve |
| BARD1 | BRCA1 Associated RING Domain 1 |
| BECN1 | Beclin 1 |
| BER | Base Excision Repair |
| BRAF | B-Raf Proto-Oncogene, Serine/Threonine Kinase |
| BRCA | BRCA, DNA Repair Associated |
| BRIP1 | BRCA1 Interacting Protein C-Terminal Helicase 1 |
| CA125 | Cancer Antigen 125 |
| CCNE1 | Cyclin E1 |
| CDKN2A | Cyclin Dependent Kinase Inhibitor 2A |
| CDKN2D | Cyclin Dependent Kinase Inhibitor 2D |
| CDK12 | Cyclin Dependent Kinase 12 |
| CHEK2 | Checkpoint Kinase 2 |
| CICs | Cortical Inclusion Cysts |
| CK7 | Cytokeratin 7 |
| CK20 | Cytokeratin 20 |
| CNAs | Copy Number Alterations |
| CT | Computer Tomography |
| CTNNB1 | Catenin Beta 1 |
| DICER | Dicer 1, Ribonuclease III |
| DNA | Deoxyribonucleic acid |
| EMA | European Medicines Agency |
| EOC | Epithelial Ovarian Cancer |
| ER | Estrogen Receptor |
| FDA | Food and Drug Administration |
| FIGO | International Federation of Gynecology and Obstetrics |
| FOXM1 | Forkhead Box M1 |
| FTSEC | Secretory Epithelial Cells of the Distal Fallopian Tube |
| GAB2 | GRB2 Associated Binding Protein 2 |
| GABRA6 | Gamma-Aminobutyric Acid Type A Receptor Alpha6 Subunit |
| g-H2AX | Gamma H2A histone family member X |
| GEMM | Genetically Engineered Mouse Models |
| GOG | Gynecologic Oncology Group |
| GWAS | Genome Wide Association Studies |
| HDM2 | HDM2 Proto-Oncogene |
| HGSOC | High Grade Serous Ovarian Cancer |
| HIF-1a | Hypoxia Inducible Factor 1 Subunit Alpha |
| HMGA2 | High Mobility Group AT-Hook 2 |
| HNF1b | HNF1 Homeobox B |
| HOXA9 | Homeobox A9 |
| IARC | International Agency for Research on Cancer |
| KRAS | KRAS Proto-Oncogene, GTPase |
| LC3 | Microtubule Associated Protein 1 Light Chain 3 Alpha |
| LOH | Loss of Heterozygosity |
| MAPK | Mitogen-Activated Protein Kinase 1 |
| MECOM | MDS1 And EVI1 Complex Locus |
| MRI | Magnetic Resonance Imaging |
| MRE11A | MRE11 Homolog, Double Strand Break Repair Nuclease |
| MYC | MYC Proto-Oncogene, BHLH Transcription Factor |
| NACT | Neoadjuvant Chemotherapy |
| NCI | American National Cancer Institute |
| NF1 | Neurofibromin 1 |
| NSG | NOD-SCID IL2R-gammanull |
| OSE | Ovarian Surface Epithelium |
| PALB2 | Partner and Localizer of BRCA2 |
| PARP | Poly (ADP-Ribose) Polymerase |
| PAX8 | Paired Box 8 |
| PDXs | Patient Derived Xerographs |
| PET | Positron-Emission Tomography |
| PI3K | Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit |
| PIK3CB | Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta |
| PIK3CA | Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha |
| PR | Progesterone Receptor |
| PTEN | Phosphatase and Tensin Homolog |
| P53 | Tumor Protein P53 |
| RAD50 | RAD50 Double Strand Break Repair Protein |
| RAD51C | RAD51 Paralog C |
| RAS | KRAS Proto-Oncogene, GTPase |
| RB | RB Transcriptional Corepressor |
| ROS | Radical Oxygen Species |
| RTK | Receptor Tyrosine Kinases |
| SCID | Severe Combined Immunodeficient |
| SEER | Surveillance Epidemiology and End Results |
| SET | Solid pseudo-Endometrioid and/or Transitional Cell Carcinoma-like |
| SNPs | Single Nucleotide Polymorphisms |
| STIC | Serous Tubal Intra Epithelial Carcinoma |
| TCGA | The Tumor Genome Atlas |
| UK | United Kingdom |
| VEGF-A | Vascular Endothelial Growth Factor A |
| WDFY2 | WD Repeat and FYVE Domain Containing 2 |
| WHO | World Health Organization |
| WNT | Wnt Family Member |
| WT1 | Wilms Tumor 1 |